Strides Pharma Science

Strides Pharma Science Revenue per Share

The Revenue per Share of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 496.12 INR. In the previous year, Revenue per Share was 427.48 INR — a change of 16.06% (higher).

Revenue per Share

496.12INR

YoY

16.06%

Last updated:

Revenue per Share of Strides Pharma Science is 2025 496.12 INR. Revenue per Share of Strides Pharma Science was 2024 427.48 INR. It decreases by 16.06% higher compared to the previous year.

The Strides Pharma Science Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2022
341.14 INR
Jan 1, 2023
409.45 INR
Jan 1, 2024
427.48 INR
Jan 1, 2025
496.12 INR
Jan 1, 2026 (e)
523.80 INR
Jan 1, 2027 (e)
609.99 INR
Jan 1, 2028 (e)
706.19 INR
Jan 1, 2029 (e)
813.01 INR
The Strides Pharma Science Revenue per Share history
YEARRevenue per ShareYoY
est813.01INR+15.13%
est706.19INR+15.77%
est609.99INR+16.45%
est523.80INR+5.58%
496.12INR+16.06%
427.48INR+4.40%
409.45INR+20.02%
341.14INR-7.41%
368.43INR+20.49%
305.78INR+26.33%
242.04INR-23.43%
316.12INR+3.26%
306.16INR-11.22%
344.84INR+73.03%
199.30INR-12.31%
227.29INR+39.43%
163.02INR-62.28%
432.20INR+27.43%
339.16INR+42.96%
237.24INR+23.23%
192.51INR-9.47%
212.66INR+17.35%
181.22INR+34.95%
134.28INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

Revenue per Share of Strides Pharma Science is 496.12 INR in 2025.

Revenue per Share of Strides Pharma Science changed from 427.48 INR to 496.12 INR, representing a 16.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Strides Pharma Science

All Key Metrics — Strides Pharma Science